INGREZZA 40 MG / 60 MG Initiation Pack
- RxCUI
- 2665628
- RxNorm name
- INGREZZA 40 MG / 60 MG Initiation Pack
- Display name
- INGREZZA 40 MG / 60 MG Initiation Pack
- Full name
- INGREZZA 40 MG / 60 MG Initiation Pack
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:57
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| INGREZZA | VALBENAZINE | Neurocrine Biosciences, Inc. | 4c970164-cafb-421f-9eb5-c226ef0a3417 | 2026-04-17 | Boxed warning, Warnings, Adverse reactions | 2665628 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 4c970164-cafb-421f-9eb5-c226ef0a3417 | {14 (valbenazine 40 MG Oral Capsule [Ingrezza]) / 14 (valbenazine 60 MG Oral Capsule [Ingrezza]) } Pack [Ingrezza 40/60 Initiation Pack] [BPCK] · INGREZZA 40 MG / 60 MG Initiation Pack [PSN] · INGREZZA 40 MG / 60 MG Initiation Pack, 28 capsules [SY] | 3 | 34 | These highlights do not include all the information needed to use INGREZZA or INGREZZA SPRINKLE safely and effectively. See full prescribing information for INGREZZA. INGREZZA ® (valbenazine) capsules, for oral use INGREZZA ® SPRINKLE (valbenazine) capsules, for oral use Initial U.S. Approval: 2017 | 20260417 |